Sivik Global Healthcare LLC Makes New $2.55 Million Investment in Bruker Co. (NASDAQ:BRKR)

Sivik Global Healthcare LLC acquired a new position in shares of Bruker Co. (NASDAQ:BRKR) during the second quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm acquired 40,000 shares of the medical research company’s stock, valued at approximately $2,552,000.

Other hedge funds have also recently added to or reduced their stakes in the company. GAMMA Investing LLC acquired a new stake in shares of Bruker in the 4th quarter valued at $33,000. Silver Oak Securities Incorporated acquired a new stake in shares of Bruker in the 4th quarter valued at $829,000. Van ECK Associates Corp boosted its holdings in shares of Bruker by 14.6% in the 4th quarter. Van ECK Associates Corp now owns 38,315 shares of the medical research company’s stock valued at $2,815,000 after purchasing an additional 4,874 shares in the last quarter. Victory Capital Management Inc. boosted its holdings in shares of Bruker by 2.8% in the 4th quarter. Victory Capital Management Inc. now owns 58,560 shares of the medical research company’s stock valued at $4,303,000 after purchasing an additional 1,599 shares in the last quarter. Finally, Buckhead Capital Management LLC acquired a new stake in shares of Bruker in the 4th quarter valued at $1,634,000. Institutional investors own 79.52% of the company’s stock.

Analysts Set New Price Targets

A number of equities research analysts have weighed in on BRKR shares. Wells Fargo & Company started coverage on Bruker in a report on Tuesday. They issued an “overweight” rating and a $78.00 target price on the stock. StockNews.com downgraded Bruker from a “buy” rating to a “hold” rating in a report on Tuesday, May 21st. The Goldman Sachs Group cut their price objective on Bruker from $72.00 to $60.00 and set a “sell” rating on the stock in a report on Tuesday, July 9th. Stifel Nicolaus cut their price objective on Bruker from $81.00 to $77.00 and set a “hold” rating on the stock in a report on Monday, May 20th. Finally, Bank of America cut their price objective on Bruker from $95.00 to $90.00 and set a “buy” rating on the stock in a report on Monday, May 20th. One investment analyst has rated the stock with a sell rating, three have given a hold rating and seven have assigned a buy rating to the company. According to data from MarketBeat.com, Bruker presently has an average rating of “Moderate Buy” and an average target price of $81.40.

Bruker Trading Down 0.5 %

BRKR traded down $0.35 during midday trading on Friday, hitting $67.19. 1,002,853 shares of the company were exchanged, compared to its average volume of 1,025,705. The firm has a market capitalization of $9.77 billion, a P/E ratio of 24.43, a P/E/G ratio of 2.39 and a beta of 1.20. Bruker Co. has a 1-year low of $53.79 and a 1-year high of $94.86. The firm’s 50 day moving average price is $63.87 and its 200-day moving average price is $74.76. The company has a quick ratio of 0.91, a current ratio of 1.81 and a debt-to-equity ratio of 0.95.

Bruker (NASDAQ:BRKR) last announced its earnings results on Tuesday, August 6th. The medical research company reported $0.52 EPS for the quarter, hitting the consensus estimate of $0.52. The firm had revenue of $800.70 million for the quarter, compared to the consensus estimate of $799.44 million. Bruker had a return on equity of 27.31% and a net margin of 13.38%. The business’s quarterly revenue was up 17.4% compared to the same quarter last year. During the same period in the previous year, the business earned $0.50 EPS. As a group, equities analysts forecast that Bruker Co. will post 2.66 EPS for the current fiscal year.

Bruker Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Monday, September 16th. Stockholders of record on Monday, September 2nd will be given a $0.05 dividend. This represents a $0.20 annualized dividend and a dividend yield of 0.30%. The ex-dividend date of this dividend is Friday, August 30th. Bruker’s dividend payout ratio (DPR) is presently 7.27%.

Bruker Profile

Bruker Corporation, together with its subsidiaries, develops, manufactures, and distributes scientific instruments, and analytical and diagnostic solutions in the United States, Europe, the Asia Pacific, and internationally. The company operates through four segments: Bruker Scientific Instruments (BSI) BioSpin, BSI CALID, BSI Nano, and Bruker Energy & Supercon Technologies.